The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse.
- 1 September 2008
- journal article
- Vol. 12 (9), 1059-64
Abstract
Patients with cavitary pulmonary tuberculosis (TB) on baseline chest radiograph (CXR) who remain culture-positive after 8 weeks of treatment are at high risk of relapse. The role of end-of-treatment (EOT) CXR in predicting relapse is unclear. To determine whether EOT CXR independently predicts TB relapse. We conducted a secondary analysis of a randomized trial of intermittent treatment using rifapentine in the continuation phase of TB treatment among 1004 human immunodeficiency virus seronegative adults with culture-proven pulmonary TB. Relapse occurred in 17.3% of subjects with persistent cavity on EOT CXR, in 7.6% of subjects with a cavity that resolved by EOT, and 2.5% (P=0.002 for trend) of subjects who never had a cavity. In multivariable analysis, patients with persistent cavity on EOT CXR were significantly more likely to relapse than patients with no cavity on baseline or 2-month CXR (hazard ratio [HR] 4.22, 95%CI 2.00-8.91), and were more likely to relapse than subjects whose early cavity had resolved by EOT CXR (HR 1.92, 95%CI 1.09-3.39). A persistent cavity after 6 months of TB treatment was independently associated with disease relapse after controlling for other variables. EOT CXR may help predict those likely to relapse.Keywords
This publication has 19 references indexed in Scilit:
- Risk Factors for Relapse and Acquired Rifamycin Resistance after Directly Observed Tuberculosis Treatment: A Comparison by HIV Serostatus and Rifamycin UseClinical Infectious Diseases, 2004
- Stable Incidence Rates of Tuberculosis (TB) among Human Immunodeficiency Virus (HIV)–Negative South African Gold Miners during a Decade of Epidemic HIV‐Associated TBThe Journal of Infectious Diseases, 2003
- TuberculosisThe Lancet, 2003
- Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?2003
- Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trialThe Lancet, 2002
- Chest radiograph abnormalities associated with tuberculosis: reproducibility and yield of active cases.2002
- The impact of HIV infection on recurrence of tuberculosis in South African gold miners.2000
- Diagnostic Standards and Classification of Tuberculosis in Adults and ChildrenAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.Published by Elsevier BV ,1986
- [Short term chemotherapy of tuberculosis. Factors affecting relapse following short term chemotherapy].1978